Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

Share Price is delayed by 15 minutes
Get Live Data
14.50    0.00 (0.00%)
Bid:
14.00
Ask:
15.00
Spread: 1.00 (7.143%)
Market Cap: £11.97m
FIPP Live PriceLast checked at - London Stock Exchange

Intraday Frontier Ip Share Chart

Elute Intelligence appoints Steve Cable as CEO

14 Oct 2022 07:00

RNS Number : 8774C
Frontier IP Group plc
14 October 2022
 

REACH

AIM: FIPP

14 October 2022

 

Frontier IP Group plc

("Frontier IP" or the "Group")

 

 

Portfolio news - Elute Intelligence appoints Steve Cable as Chief Executive Officer

 

Frontier IP, a specialist in commercialising intellectual property, today announces that portfolio company Elute Intelligence Holdings Limited ("Elute" or the "Company") has appointed Steve Cable as Chief Executive Officer. Steve will guide the organisation through the development of existing Elute products with an emphasis on product alignment, market traction and commercial growth.

 

Steve has more than 25 years' experience in building businesses at start-ups, mid-size firms and large companies. He has worked with software solutions in Artificial Intelligence, Search, Professional Services Automation, Enterprise Resource Planning, and Identity Management across a wide diversity of sectors.

 

His experience of leading strategy, positioning solutions, and penetrating existing markets, is a core requirement for Elute. This was recently demonstrated where he was part of leadership team at CMap Software. The Company went from being a relatively unknown start up to industry leader with more than £4m annual recurring revenues, leading to a private equity investment in December 2019.

 

The Elute technology is based on encoding forensic linguistic principles in software. The core competency enables documents to be read in a manner similar to humans, but by a computer at great speed. It is possible for the system to 'read' millions of documents in seconds and identify the documents that are of greatest relevance. The software can clearly show the user why documents are relevant, a marked difference to artificial intelligence or semantic search approaches used by competing products.

 

Other complementary competencies allow rapid detailed comparison of text in documents, authorship detection for plagiarism and collusion detection, and an ability to automatically summarise documents. While Elute's current products are English language based, the functionality is not language dependent and therefore the products could in principle be applied to a wide range of languages including English, Russian, Arabic and Chinese.

 

The technology is live, proven, and trusted by organisations such as UCAS and the Open University.

 

Steve Cable, Elute Chief Executive Officer, said: "I joined Elute due to the many possible applications of the technology. I've had the benefit of working in two of the UK's leading SaaS search software providers, so I immediately recognised the possibilities. In the short time I've been on board we have made big strides and we expect to be able to launch a new differentiated product very soon. My primary aim is taking this technology to market, gaining user feedback, and monetising as soon as possible." 

 

Frontier IP Chief Executive Neil Crabb said: "Elute has the potential to transform the way in which we search and compare text stored in large, complex, and unstructured datasets. We are very pleased that Steve has been appointed Elute's Chief Executive. He has already made great progress since he joined the Company, and we are looking forward to working with him as CEO as he takes it forward to success."

 

ENQUIRIES

Frontier IP Group Plc

T: 020 7332 2338

Neil Crabb, Chief Executive

Andrew Johnson, Communications and investor relations

andrew.johnson@frontierip.co.uk

Company website: www.frontierip.co.uk

neil@frontierip.co.uk

M: 07464 546 025

Allenby Capital Limited (Nominated Adviser)

T: 0203 328 5656

Nick Athanas / George Payne

 

ABOUT FRONTIER IP

Frontier IP unites science, finance and industry by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

About Reach announcements

This is a RNS Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFFFEDDEESESS
Date   Source Headline
29th Dec 20201:44 pmRNSHolding(s) in Company
17th Dec 202012:30 pmRNSResult of AGM
1st Dec 20207:00 amRNSCambridge Raman participates in EUR 5m project
20th Nov 20207:00 amRNSPosting of Annual Report and Notice of AGM
16th Nov 20207:00 amRNSFrontier IP: recording of annual results webcast
16th Nov 20207:00 amRNSPortfolio news – Fieldwork SIF grant
13th Nov 20202:03 pmRNSHolding(s) in Company
10th Nov 20207:00 amRNSAlusid - £125,000 backing from UK Future Fund
9th Nov 20206:03 pmRNSDirectors’ Dealings
6th Nov 20203:07 pmRNSHolding(s) in Company
5th Nov 20202:34 pmRNSGrant of Options
5th Nov 20207:00 amRNSAnnual results webcast hosted by LSE
5th Nov 20207:00 amRNSFinal Results
26th Oct 20207:00 amRNSPublication of newsletter
15th Oct 20207:00 amRNSTVG collaboration - Pirbright & ECO Animal Health
21st Sep 20207:00 amRNSBonduelle collaboration with Fieldwork Robotics
16th Sep 20207:00 amRNSUK Gov Future Fund invests £360k in Nandi Proteins
14th Sep 20207:00 amRNSInnovate UK backs Fieldwork Robotics with grant
9th Sep 20205:11 pmRNSHolding(s) in Company
7th Sep 20207:00 amRNSSoftware Commercialisation Director appointment
1st Sep 20207:00 amRNSElute Intelligence Patent Reader launched
24th Aug 20205:48 pmRNSHolding(s) in Company
10th Aug 20207:00 amRNSUK Gov Future Fund invests £250,000 in Pulsiv
5th Aug 20206:24 pmRNSHolding(s) in Company
4th Aug 20202:45 pmRNSHolding(s) in Company
31st Jul 20205:00 pmRNSTotal Voting Rights
30th Jul 202011:45 amRNSHolding(s) in Company
29th Jul 20202:46 pmRNSHolding(s) in Company
29th Jul 20209:11 amRNSHolding(s) in Company
28th Jul 20205:22 pmRNSHolding(s) in Company
22nd Jul 202012:50 pmRNSHolding(s) in Company
21st Jul 20209:05 amRNSSecond Price Monitoring Extn
21st Jul 20209:00 amRNSPrice Monitoring Extension
21st Jul 20207:00 amRNSResult of Capital Raising
20th Jul 20204:37 pmRNSPrimaryBid.com Offer
20th Jul 20204:35 pmRNSProposed Capital Raising of a minimum of £2m
20th Jul 20202:00 pmRNSCambridge Raman Imaging completes £250,000 funding
14th Jul 20207:00 amRNSAquaInSilico wins grant to commercialise software
13th Jul 20207:00 amRNSPulsiv demonstrates strong progress
7th Jul 20207:00 amRNSCelerum supports development for PlanSea Solutions
6th Jul 20207:00 amRNSBosch collaboration with Fieldwork
30th Jun 20205:00 pmRNSTotal Voting Rights
23rd Jun 20207:00 amRNSThe Vaccine Group: strong COVID-19 progress
17th Jun 20207:00 amRNSCambridge & FIPP collaborate to tackle gum disease
28th May 20207:10 amRNSPortfolio news: Access to Elute's Patent Reader
28th May 20207:00 amRNSExercise of Options and Total Voting Rights
26th May 20207:00 amRNSPortfolio news – Exscientia raises $60 million
7th May 20207:00 amRNSExscientia and SRI International collaborate
1st May 20207:00 amRNSPortfolio news – Molendotech raises £425,000
15th Apr 20207:00 amRNSPortfolio news – Pulsiv Solar awarded patent

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.